Diamedica Therapeutics Inc Share Price

NASDAQ: DMAC

Small Cap

$6.87

-0.10

(-1.43%)

as on September 18, 2025 at 1:29 am IST

$₹

Diamedica Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$6.82
Day's Price Range
$7.18
$6.87
0.73%
Downside
4.51%
Upside
52 Week's Low
52 Week's High
$3.19
52-Week Price Range
$7.49
$6.87
53.57%
Downside
9.02%
Upside

Diamedica Therapeutics Inc share price movements today

Previous Close: $6.97
Open: $6.93
Volume: 309.9K
Day's Low - High: $6.82 - $7.18
52 Week Low - High: $3.19 - $7.49

Diamedica Therapeutics Inc Historical Returns

1 Month Return: + 15.59 %
3 Month Return: + 95.24 %
1 Year Return: + 60.23 %
3 Year Return: + 384.03 %
5 Year Return: + 58.05 %

Diamedica Therapeutics Inc Stock Fundamentals & Key Indicators

Check Diamedica Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$360.3M

EPS (TTM)

-0.68

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-31.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

5326000.00%

Diamedica Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Diamedica Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Diamedica Therapeutics Inc	BUY	$360.3M	58.05%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Diamedica Therapeutics Inc Stock including INR - Dollar returns

The Diamedica Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Diamedica Therapeutics Inc investment value today

Current value as on today

₹1,62,529

Returns

₹62,529

(+62.53%)

Returns from Diamedica Therapeutics Inc Stock

₹57,931 (+57.93%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Diamedica Therapeutics Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Diamedica Therapeutics Inc. Average target price of $12.33

Diamedica Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Diamedica Therapeutics Inc.

What analysts predicted

44.28%UPSIDE

Target Price

$12.33

Current Price

$6.87

Analyzed by

9 Analysts

Target

$12.33

Diamedica Therapeutics Inc target price $12.33, a slight upside of 44.28% compared to current price of $6.87. According to 9 analysts rating.

Diamedica Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Diamedica Therapeutics Inc Stock has increased by 263% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:263% versus previous 30 day period

Diamedica Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	30	-	-	-	13	-	-
Gross Profit	-5	-4	-5	0	0	0	-6	6	0	0
Operating Income	-5	-4	-10	-5	-5	-5	-6	-8	-8	-8
EBITDA	-5	-4	-5	-5	-5	-5	-6	-8	-8	-7
Interest Expense	5	-	-	5	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-4	-4	-5	-5	-5	-6	-7	-7	-7
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-5	-4	-4	-5	-5	-5	-6	-7	-7	-7
Net Profit Margin	0.00%	0.00%	0.00%	-16.74%	0.00%	0.00%	0.00%	-57.24%	0.00%	0.00%

Diamedica Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	0	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-1	-2	-4	-6	-11	-12	-13	-14	-21	-26
EBITDA	-1	-2	-4	-5	-10	-12	-13	-13	-19	-24
Interest Expense	0	0	-	-	0	0	0	0	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-1	-2	-4	-5	-10	-12	-13	-13	-19	-24
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-1	-2	-4	-5	-10	-12	-13	-13	-19	-24
Net Profit Margin	0.00%	0.00%	0.00%	-1146.80%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Diamedica Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-4	-5	-5	-5	-6	-7	-7	-7
Operating Cash Flow	-5	-4	-3	-6	-4	-4	-6	-7	-7
Investing Cash Flow	-28	1	6	4	4	-5	5	6	8
Financing Cash Flow	36	0	0	0	11	0	0	0	0
Change in Cash	3	-3	2	-2	11	-9	-1	0	1

Diamedica Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-4	-5	-10	-12	-13	-13	-19	-24
Operating Cash Flow	-3	-3	-5	-9	-9	-12	-11	-18	-22
Investing Cash Flow	0	0	0	-3	-16	-20	11	-18	8
Financing Cash Flow	4	3	21	0	28	30	0	36	11
Change in Cash	1	0	15	-12	3	-2	0	0	-1

Global Institutional Holdings in Diamedica Therapeutics Inc

Funds	Holdings
Cooperman Leon G	3.16%
Vanguard Group Inc	2.62%
First Manhattan Co. LLC	1.18%
PARAGON Assoc & PARAGON Assoc II JV	1.17%
Susquehanna International Group, LLP	1.08%

See all

Insights on Diamedica Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, DMAC has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -7.9M → -7.69M (in $), with an average increase of 1.3% per quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, DMAC stock has moved up by 21.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 0.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 30.83M → 13.80M (in $), with an average decrease of 55.2% per quarter

About Diamedica Therapeutics Inc

diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit www.diamedica.com.

Organisation	Diamedica Therapeutics Inc
Headquarters	301 Carlson Parkway, Minneapolis, MN, United States, 55305
Industry	Health Technology
CEO	Mr. Dietrich John Pauls MBA
E-voting on shares	Click here to vote

Key Management of Diamedica Therapeutics Inc

Name	Title
Mr. David J. Wambeke	Chief Business Officer
Dr. Alex Aimetti Ph.D.	Chief Development Officer
Dr. Julie Krop M.D.	Chief Medical Officer
Mr. Dietrich John Pauls MBA	President, CEO & Director
Mr. Scott Kellen CPA	CFO & Corporate Secretary
Dr. Ambarish Shah Ph.D.	Chief Technology Officer
Mr. Dominic R. Cundari	Chief Commercial Officer

FAQs

What is Diamedica Therapeutics Inc share price today?

Diamedica Therapeutics Inc share price today is $6.87 as on September 18, 2025 at 1:29 am IST at the close of the market. Diamedica Therapeutics Inc share today touched a day high of $7.18 and a low of $6.82.

What is the 52 week high and 52 week low for Diamedica Therapeutics Inc share?

Diamedica Therapeutics Inc share touched a 52 week high of $7.49 on September 8, 2025 and a 52 week low of $3.19 on April 7, 2025. Diamedica Therapeutics Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $6.87,which is 8.28% down from its 52 week high and 115.36% up from its 52 week low.

What is Diamedica Therapeutics Inc's market capitalisation today?

Diamedica Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Diamedica Therapeutics Inc Stock (DMAC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Diamedica Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Diamedica Therapeutics Inc Shares that will get you 0.2183 shares as per Diamedica Therapeutics Inc share price of $6.87 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Diamedica Therapeutics Inc Stock (DMAC) from India?

Indian investors can start investing in Diamedica Therapeutics Inc (DMAC) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 6:36 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Diamedica Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 6:36 am IST). Based on Diamedica Therapeutics Inc share’s latest price of $6.87 as on September 18, 2025 at 1:29 am IST, you will get 1.4556 shares of Diamedica Therapeutics Inc. Learn more about fractional shares .

What are the returns that Diamedica Therapeutics Inc has given to Indian investors in the last 5 years?

Diamedica Therapeutics Inc stock has given 58.05% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?